Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes. (Q50796108)

From Wikidata

Jump to navigation Jump to search

scientific article published on 24 January 2013

Language	Label	Description	Also known as
English	Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes.	scientific article published on 24 January 2013

Statements

scholarly article

1 reference

Europe PubMed Central

19 March 2018

http://europepmc.org/abstract/MED/23344731

Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes. (English)

1 reference

Europe PubMed Central

19 March 2018

http://europepmc.org/abstract/MED/23344731

atherosclerosis

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

19 March 2018

http://europepmc.org/abstract/MED/23344731

12

1 reference

Europe PubMed Central

19 March 2018

http://europepmc.org/abstract/MED/23344731

author name string

M Olukman

2

1 reference

Europe PubMed Central

19 March 2018

http://europepmc.org/abstract/MED/23344731

C Koulis

3

1 reference

Europe PubMed Central

19 March 2018

http://europepmc.org/abstract/MED/23344731

Y Tu

4

1 reference

Europe PubMed Central

19 March 2018

http://europepmc.org/abstract/MED/23344731

D Samijono

5

1 reference

Europe PubMed Central

19 March 2018

http://europepmc.org/abstract/MED/23344731

D Yuen

6

1 reference

Europe PubMed Central

19 March 2018

http://europepmc.org/abstract/MED/23344731

C Lee

7

1 reference

Europe PubMed Central

19 March 2018

http://europepmc.org/abstract/MED/23344731

D J Behm

8

1 reference

Europe PubMed Central

19 March 2018

http://europepmc.org/abstract/MED/23344731

M E Cooper

9

1 reference

Europe PubMed Central

19 March 2018

http://europepmc.org/abstract/MED/23344731

K A M Jandeleit-Dahm

10

1 reference

Europe PubMed Central

19 March 2018

http://europepmc.org/abstract/MED/23344731

A C Calkin

11

1 reference

Europe PubMed Central

19 March 2018

http://europepmc.org/abstract/MED/23344731

publication date

24 January 2013

1 reference

Europe PubMed Central

19 March 2018

http://europepmc.org/abstract/MED/23344731

1 reference

Europe PubMed Central

19 March 2018

http://europepmc.org/abstract/MED/23344731

56

1 reference

Europe PubMed Central

19 March 2018

http://europepmc.org/abstract/MED/23344731

5

1 reference

Europe PubMed Central

19 March 2018

http://europepmc.org/abstract/MED/23344731

1155-1165

1 reference

Europe PubMed Central

19 March 2018

http://europepmc.org/abstract/MED/23344731

https://scigraph.springernature.com/pub.10.1007/s00125-013-2837-9

0 references

Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14).

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

A novel putative neuropeptide receptor expressed in neural tissue, including sensory epithelia.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

From 'gills to pills': urotensin-II as a regulator of mammalian cardiorenal function

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Urotensin II: the old kid in town.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Increased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aorta

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Targeted overexpression of the human urotensin receptor transgene in smooth muscle cells: effect of UT antagonism in ApoE knockout mice fed with Western diet

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Human urotensin II accelerates foam cell formation in human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

The urotensin-II receptor antagonist palosuran improves pancreatic and renal function in diabetic rats

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Effect of the urotensin receptor antagonist palosuran in hypertensive patients with type 2 diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Increased plasma urotensin II levels in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Human urotensin II induces tissue factor and cellular adhesion molecules expression in human coronary endothelial cells: an emerging role for urotensin II in cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Role of prostaglandins in urotensin II-induced vasodilatation in the coronary arteries of aged rats

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

NOX4 mediates activation of FoxO3a and matrix metalloproteinase-2 expression by urotensin-II

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Role of oxidative stress in diabetes-mediated vascular dysfunction: unifying hypothesis of diabetes revisited

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Antioxidants in the treatment of diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

G-protein-coupled receptors in human atherosclerosis: comparison of vasoconstrictors (endothelin and thromboxane) with recently de-orphanized (urotensin-II, apelin and ghrelin) receptors.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Urotensin II acts centrally to increase epinephrine and ACTH release and cause potent inotropic and chronotropic actions

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

The pro-angiogenic activity of urotensin-II on human vascular endothelial cells involves ERK1/2 and PI3K signaling pathways.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Proliferation and anti-apoptotic effects of human urotensin II on human endothelial cells

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Local non-esterified fatty acids correlate with inflammation in atheroma plaques of patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Cellular distribution of immunoreactive urotensin-II in human tissues with evidence of increased expression in atherosclerosis and a greater constrictor response of small compared to large coronary arteries

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Immunocytochemical localization of the urotensin-II receptor, UT, to rat and human tissues: Relevance to function

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Lack of the Antioxidant Enzyme Glutathione Peroxidase-1 Accelerates Atherosclerosis in Diabetic Apolipoprotein E–Deficient Mice

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2837-9

21 January 2018

Glycohemoglobin measured by automated affinity HPLC correlates with both short-term and long-term antecedent glycemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23344731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased cyclooxygenase-2 expression and prostaglandin-mediated dilation in coronary arterioles of patients with diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/23344731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A noninvasive computerized tail-cuff system for measuring blood pressure in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/23344731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated expression of urotensin II and its receptor in skeletal muscle of diabetic mouse

1 reference

https://pubmed.ncbi.nlm.nih.gov/23344731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-013-2837-9

1 reference

Europe PubMed Central

19 March 2018

http://europepmc.org/abstract/MED/23344731

1 reference

Europe PubMed Central

19 March 2018

http://europepmc.org/abstract/MED/23344731

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50796108&oldid=1416659000"